SFS
CPRX

Sowell Financial Services’s Catalyst Pharmaceutical CPRX Stock Holding History

Sowell Financial Services’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,784
Closed -$8K – 957
2021
Q1 		$8K Buy
1,784
+1,349
+310% +$5.36K ﹤0.01% 2395
2020
Q4 		$1K Hold
435
– – ﹤0.01% 2554
2020
Q3 		$1K Hold
435
– – ﹤0.01% 2337
2020
Q2 		$2K Hold
435
– – ﹤0.01% 2134
2020
Q1 		$2K Hold
435
– – ﹤0.01% 2046
2019
Q4 		$2K Hold
435
– – ﹤0.01% 2169
2019
Q3 		$2K Buy
+435
New +$2.32K ﹤0.01% 2048

Other funds holding CPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sowell Financial Services's CPRX Position: Q2 2021 in Review

Sowell Financial Services sold out of Catalyst Pharmaceutical (CPRX) in Q2 2021, closing a stake of 1,784 shares — an estimated $8K sold.

Sowell Financial Services first reported a position in CPRX in Q3 2019 and held it in 7 quarters. The position peaked at $8K in Q1 2021. 139 funds tracked by Wall St. Rank hold CPRX as of Q2 2021.

  • Sowell Financial Services reported no remaining Catalyst Pharmaceutical position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,784 Catalyst Pharmaceutical shares in Q2 2021, an estimated $8K.
  • Sowell Financial Services first reported a position in Catalyst Pharmaceutical in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Catalyst Pharmaceutical position peaked at $8K in Q1 2021.
  • 139 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.